Log In
BCIQ
Print this Print this
 

ALB-137391(a)

  Manage Alerts
Collapse Summary General Information
Company Albany Molecular Research Inc.
Description5-HT3 receptor partial agonist
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5HT3) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat irritable bowel syndrome (IBS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today